CA1078736A - Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole - Google Patents

Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole

Info

Publication number
CA1078736A
CA1078736A CA286,281A CA286281A CA1078736A CA 1078736 A CA1078736 A CA 1078736A CA 286281 A CA286281 A CA 286281A CA 1078736 A CA1078736 A CA 1078736A
Authority
CA
Canada
Prior art keywords
carbamoyl
day
active ingredient
hydroxyimidazole
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA286,281A
Other languages
English (en)
Inventor
Noboru Yoshida
Takao Kiyohara
Shigeo Ogino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Application granted granted Critical
Publication of CA1078736A publication Critical patent/CA1078736A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA286,281A 1976-09-07 1977-09-07 Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole Expired CA1078736A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51107520A JPS604802B2 (ja) 1976-09-07 1976-09-07 制癌剤

Publications (1)

Publication Number Publication Date
CA1078736A true CA1078736A (fr) 1980-06-03

Family

ID=14461270

Family Applications (1)

Application Number Title Priority Date Filing Date
CA286,281A Expired CA1078736A (fr) 1976-09-07 1977-09-07 Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole

Country Status (6)

Country Link
JP (1) JPS604802B2 (fr)
AU (1) AU509455B2 (fr)
CA (1) CA1078736A (fr)
DE (1) DE2740281A1 (fr)
FR (1) FR2363329A1 (fr)
NL (1) NL7709853A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582845A (en) * 1980-11-05 1986-04-15 Sumitomo Pharmaceuticals Co., Ltd. Pharmaceutical composition for injection
US4728729A (en) * 1984-03-14 1988-03-01 Sumitomo Pharmaceuticals Co., Ltd. Cyanoimidazole nucleoside derivatives

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU507066B1 (en) * 1977-09-06 1980-01-31 Sumitomo Chemical Company, Limited 2-Substituted-5-Hydroxy-1h-Imidazole 4-Carbozamide Derivatives
JPS5495568A (en) * 1978-01-06 1979-07-28 Sumitomo Chem Co Ltd Novel imidazoleacetic acid derivative
AU530916B2 (en) * 1979-08-08 1983-08-04 Sumitomo Chemical Company, Limited 4-carbamoyl imidazolium-5-olate derivatives
JPS5780317A (en) * 1980-11-05 1982-05-19 Sumitomo Chem Co Ltd Preparation of pharmaceutical composition for injection
US4464531A (en) * 1981-04-20 1984-08-07 Sumitomo Chemical Company, Limited 4-Carbamoylimidazolium-5-olate derivatives
JPS6089418A (ja) * 1983-10-20 1985-05-20 Sumitomo Chem Co Ltd 徐放性制癌剤
ATE250481T1 (de) * 1998-11-13 2003-10-15 Elpatronic Ag Verfahren zum schweissen von rohren sowie einrichtung zu dessen durchführung
JP5266010B2 (ja) 2007-09-14 2013-08-21 富士フイルム株式会社 ４−カルバモイル−５−ヒドロキシ−イミダゾール誘導体のスルホン酸塩化合物
EP2946763A4 (fr) 2013-01-15 2016-07-27 Fujifilm Corp Emballage pour préparation solide comprenant du 5-hydroxy-1h-imidazole-4-carboxamide ou un sel ou hydrate de celui-ci
CN104271134B (zh) 2013-01-15 2016-06-29 富士胶片株式会社 含有5-羟基-1h-咪唑-4-甲酰胺的片剂
EP2947069B1 (fr) 2013-01-15 2017-11-22 FUJIFILM Corporation Sulfate de 5-hydroxy-1h-imidazole-4-carboxamide
WO2015105174A1 (fr) 2014-01-10 2015-07-16 富士フイルム株式会社 Procédé de prédiction et dispositif de prédiction de dose efficace/sensibilité de 5-hydroxy-1h-imidazole-4-carboxamide, procédé de mesure de quantité de monophosphate de xanthosine, et agent de traitement et procédé de traitement de syndrome myélodysplasique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52101855A (en) * 1976-02-21 1977-08-26 Toyo Seisakusho Kk Air moistener

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582845A (en) * 1980-11-05 1986-04-15 Sumitomo Pharmaceuticals Co., Ltd. Pharmaceutical composition for injection
US4728729A (en) * 1984-03-14 1988-03-01 Sumitomo Pharmaceuticals Co., Ltd. Cyanoimidazole nucleoside derivatives

Also Published As

Publication number Publication date
AU2861977A (en) 1979-03-15
FR2363329A1 (fr) 1978-03-31
DE2740281A1 (de) 1978-03-09
JPS5332124A (en) 1978-03-27
AU509455B2 (en) 1980-05-15
JPS604802B2 (ja) 1985-02-06
FR2363329B1 (fr) 1981-01-23
NL7709853A (nl) 1978-03-09

Similar Documents

Publication Publication Date Title
CA1078736A (fr) Usages therapeutiques du 4-carbamoyl-5-hydroxyimidazole
Conti et al. Protective activity of silipide on liver damage in rodents
US4181731A (en) Novel therapeutic application of 4-carbamoyl-5-hydroxyimidazole
EP0066918A1 (fr) Compositions anti-inflammatoires causant un dommage gastrique minimalisé
CA2286557A1 (fr) Phorbol esters utilises en tant qu'agents anti-neoplasiques
JP2001513506A (ja) タイプｉｉ糖尿病のクロム／ビオチン治療
US4963559A (en) Method of treating cancer and cancer metastasis
EP0313654B1 (fr) Medicament pour la prophylaxie et le traitement de l'hepatopathie
US4291048A (en) Method of treating tumors and cancerous cachexia with L-tryptophan
JPS63270626A (ja) 抗潰瘍剤
US5661188A (en) Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)
WO1989005637A1 (fr) Courbes de toxicite ameliorees en chimiotherapie
JP2688057B2 (ja) 抗腺がん剤
US4814353A (en) Therapeutic and prophylactic agent for gastritis
Chrysant et al. Hemodynamic and metabolic effects of hypomagnesemia in spontaneously hypertensive rats
US5116600A (en) Composition and method for inhibiting inflammation caused by non-parenteral administration of 5-fluorouracil type compounds
MXPA97000967A (en) Therapeutic use of acetazolamide for the treatment of edema cereb
US4892876A (en) Method for inhibiting HIV and an pharmaceutical composition therefor
EP0140958B1 (fr) Combinaisons de medicaments oncolytiques
US6306901B1 (en) Agent for prophylaxis and therapy of diseases
US4963588A (en) Use of ubenimex for treating myelodysplastic syndrome
CA2000469A1 (fr) Methode pour ameliorer le fonctionnement du myocarde apres un accident ischemique en utilisant un inhibiteur de l'enzyme de conversion seul ou combine avec un agent thrombolytique et combinaison
EP0623346A1 (fr) Inhibiteur de la metastase d'une tumeur maligne
KR20020031404A (ko) 혈장 대체 조성물
US5475026A (en) Agent for treating hepatic diseases

Legal Events

Date Code Title Description
MKEX Expiry